Peptinovo Biopharma

About:

Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.

Website: https://peptinovo.com

Description:

Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects. The company has strong knowledge of the drug discovery and development process gained during the many years the founders worked for large pharmaceutical companies.

Total Funding Amount:

$1.32M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2014-01-01

Founders:

Bill Elliott, Reynold Homan

Number of Employees:

Last Funding Date:

2024-09-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai